90/100BNewmont stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Newmont is 135.56, 20.3% above the current price of 112.71. Their targets range from 110.00 to 154.00.
Of the 12 firms that rated Newmont in the past 12 months, 11 rate it buy or strong buy, 1 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 110.00 to 154.00, with an average of 135.56.
| Buy | 11 | |
| Hold | 1 | |
| Sell | 0 |
12-month price target
| Highest target | 154.00 |
| Average target | 135.56 |
| Lowest target | 110.00 |
| Current price | 112.71 |
Newmont price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Newmont price target and rating?
How analysts rate Newmont, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
11 of 12 firms rate it buy now, against 8 of 9 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Newmont analyst upgrades, downgrades and price targets
The latest rating change came on 22 October 2026, when Freedom Broker downgraded Newmont from Buy to Hold. The most recent new target came from Scotiabank on 27 October 2026: 148.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 27 Oct 2026 | Scotiabank Tanya Jakusconek | Reiterated · Sector Outperform | 149.00 → 148.00 | -0.7% | 112.12 |
| 22 Oct 2026 | Freedom Broker | Downgraded · Buy → Hold | — | — | — |
| 19 Oct 2026 | Barclays | Reiterated · Overweight | 124.00 → 123.00 | -0.8% | 118.60 |
| 16 Oct 2026 | CIBC | — | 170.00 → 154.00 | -9.4% | 119.56 |
| 9 Sept 2026 | Bernstein | Reiterated · Outperform | 144.00 | — | 127.09 |
| 24 Aug 2026 | Raymond James Brian MacArthur | — | 111.00 → 140.00 | +26.1% | 130.96 |
| 14 Aug 2026 | CIBC | — | 168.00 → 170.00 | +1.2% | 117.85 |
| 12 Aug 2026 | Scotiabank | Reiterated · Sector Outperform | 147.00 → 149.00 | +1.4% | 119.62 |
| 3 Aug 2026 | Argus Research Alexandra Yates | — | 110.00 | — | 93.87 |
| 28 Jul 2026 | CIBC Anita Soni | — | 175.00 → 168.00 | -4.0% | 91.64 |
| 28 Jul 2026 | Barclays Richard Garchitorena | Reiterated · Overweight | 125.00 → 124.00 | -0.8% | 93.47 |
| 15 Jul 2026 | Barclays | — | 133.00 → 125.00 | -6.0% | 95.05 |
| 14 Jul 2026 | Scotiabank | Reiterated · Sector Outperform | 152.00 → 147.00 | -3.3% | 94.88 |
| 14 Jul 2026 | TD Cowen | Upgraded · Hold → Buy | — | — | — |
| 9 Jul 2026 | RBC Capital Josh Wolfson | Reiterated · Outperform | 95.00 → 135.00 | +42.1% | 94.52 |
| 6 Jul 2026 | Jefferies | Reiterated · Buy | 120.00 → 146.00 | +21.7% | 97.04 |
| 30 Jun 2026 | UBS | Reiterated · Buy | 140.00 → 120.00 | -14.3% | 92.35 |
| 1 Jun 2026 | CIBC Anita Soni | — | 176.00 → 175.00 | -0.6% | 107.23 |
| 21 May 2026 | Barclays | — | 133.00 | — | 108.33 |
| 27 Apr 2026 | TD Securities Steven Green | — | 129.00 | — | 120.70 |
| 24 Apr 2026 | BMO Capital Matthew Murphy | Reiterated · Outperform | 140.00 → 145.00 | +3.6% | 117.87 |
| 21 Apr 2026 | CIBC Anita Soni | Reiterated · Outperform | 177.00 → 176.00 | -0.6% | 110.51 |
| 16 Apr 2026 | National Bank Shane Nagle | — | 130.00 | — | 113.41 |
| 27 Mar 2026 | UBS | Reiterated · Buy | 160.00 → 140.00 | -12.5% | 102.10 |
| 27 Feb 2026 | Bernstein | Upgraded · Market Perform → Market Outperform | — | — | — |
| 20 Feb 2026 | BMO Capital Matthew Murphy | — | 140.00 | — | 121.02 |
| 10 Feb 2026 | Stifel Nicolaus | — | 175.00 | — | 120.39 |
| 4 Feb 2026 | CIBC | — | 112.00 → 177.00 | +58.0% | 114.36 |
| 30 Jan 2026 | UBS | — | 125.00 → 160.00 | +28.0% | 117.25 |
| 26 Jan 2026 | Scotiabank | Reiterated · Sector Outperform | 114.00 → 152.00 | +33.3% | 128.69 |
| 29 Dec 2025 | Raymond James | — | 99.00 → 111.00 | +12.1% | 100.47 |
| 7 Dec 2025 | Jefferies Fahad Tariq | — | 120.00 | — | 89.76 |
| 5 Dec 2025 | BNP Paribas | — | 97.00 | — | 90.72 |
| 1 Dec 2025 | UBS Daniel Major | Reiterated · Buy | 105.50 → 125.00 | +18.5% | 91.82 |
Newmont EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does Newmont beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 24.7% off the result, either way, and their revenue estimate 7.7%, over the last 12 quarters.
- EPS beats
- 78 / 136
- Revenue beats
- 73 / 120
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +23.4%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 22 Oct 2026 | 1.96 | 2.20 | +12.2% | 6.27B | 6.36B | +1.5% |
| Q2 FY2026 | 23 Jul 2026 | 1.99 | 2.10 | +5.5% | 6.35B | 6.12B | -3.7% |
| Q1 FY2026 | 23 Apr 2026 | 2.07 | 2.90 | +40.1% | 6.77B | 7.31B | +8.0% |
| Q4 FY2025 | 19 Feb 2026 | 2.07 | 2.52 | +21.7% | 6.23B | 6.82B | +9.5% |
| Q3 FY2025 | 23 Oct 2025 | 1.44 | 1.71 | +18.8% | 5.19B | 5.38B | +3.6% |
| Q2 FY2025 | 24 Jul 2025 | 0.91 | 1.43 | +58.0% | 4.70B | 5.28B | +12.3% |
| Q1 FY2025 | 23 Apr 2025 | 0.92 | 1.25 | +36.5% | 4.70B | 5.01B | +6.5% |
| Q4 FY2024 | 20 Feb 2025 | 1.11 | 1.40 | +26.1% | 5.15B | 5.72B | +11.2% |
| Q3 FY2024 | 23 Oct 2024 | 0.86 | 0.81 | -5.8% | 4.63B | 4.60B | -0.7% |
| Q2 FY2024 | 24 Jul 2024 | 0.62 | 0.72 | +16.1% | 4.13B | 4.31B | +4.3% |
| Q1 FY2024 | 25 Apr 2024 | 0.36 | 0.55 | +53.0% | 3.66B | 4.00B | +9.3% |
| Q4 FY2023 | 22 Feb 2024 | 0.51 | 0.50 | -2.0% | 5.02B | 3.96B | -21.2% |
Newmont stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Newmont's earnings grow at the 18.2% a year analysts expect to FY2028, then 15.0% a year, it would earn about 15.07 a share in FY2030. At the P/E it has traded at over the last five years (13.0 to 42.5) that is 196.17 to 640.32 a share, or 316.98 at its average P/E of 21.0. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 9.32 | 121.26 | 195.94 | 395.81 |
| FY2027 | 9.92 | 129.14 | 208.68 | 421.55 |
| FY2028 | 11.40 | 148.33 | 239.68 | 484.18 |
| FY2029 (extrapolated) | 13.11 | 170.58 | 275.64 | 556.80 |
| FY2030 (extrapolated) | 15.07 | 196.17 | 316.98 | 640.32 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (13.0, 21.0, 42.5).
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.